Treatment Evolutions & Approaches in the Management of Prostate Cancer: Bridging the Gap between Science & Patients
Type
Webinar
EVENT DETAILS
Display Date
Tuesday September 20, 2022 // 16:00-17:00 PT ◦ 19:00-20:00 ET ◦ 20:00-21:00 AT
Location
Virtual
Speaker
Fred Saad & Urban Emmenegger
ACCREDITATION
Accreditation
1 Section 1 Group Learning Credit
Event Description
Speakers:
Fred Saad
Professor and Chief of Urology
Director of GU Oncology
Raymond Garneau Chair in Prostate Cancer
University of Montreal Hospital Center (CHUM)
Director, Prostate Cancer Research
Montreal Cancer Institute/CRCHUM
Urban Emmenegger
Medical Oncologist, Division of Medical Oncology, Odette Cancer Centre
Associate Scientist, Biological Sciences Platform, Sunnybrook Research Institute
Associate Professor, Department of Medicine, University of Toronto
Objectives:
- Recognize the DNA damage response (DDR) gene mutations that are involved in prostate cancer, and their implications for therapy
- Integrate genetic testing for patients with prostate cancer into their clinical practice
- Describe the mechanism of action, efficacy, and safety of PARP inhibitors in order to employ these agents for the treatment of prostate cancer with DDR mutations
- Explain the timing, monitoring, and management of adverse events
Footer
Sponsors:
